Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 9/20 | 0.59 |
| ▸ | MEN1 | O00255 | 8/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7700654 | 0.86 | MEN1 (0.69) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL15480439 | 0.85 | MEN1 (0.68) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL18660186 | 0.85 | MEN1 (0.68) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL14548190 | 0.81 | MEN1 (0.63) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL7121725 | 0.81 | KMT2A (0.70) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL1520465 | 0.81 | MEN1 (0.84) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL4746770 | 0.81 | MEN1 (0.63) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL16322249 | 0.79 | MEN1 (0.61) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL15480467 | 0.79 | MEN1 (0.78) | KMT2AMEN1ALDH1A1HPGDCYP2C9 | |
| SCHEMBL16322460 | 0.79 | MEN1 (0.61) | KMT2AMEN1ALDH1A1HPGDCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661398-B2 | Cellular transport system for transferring a sulfonic acid construct carrying a cargo into the cytoplasm of a cell | Scientist of Fortune, S.A. (LU) | 2023-05-30 | — | — | US | disclosed |
| US-20210009513-A1 | CELLULAR TRANSPORT SYSTEM FOR TRANSFERRING A SULFONIC ACID CONSTRUCT CARRYING A CARGO INTO THE CYTOPLASM OF A CELL | Scientist of Fortune, S.A. (LU) | 2021-01-14 | — | — | US | disclosed |
| EP-3692022-A1 | CELLULAR TRANSPORT SYSTEM FOR TRANSFERRING A SULFONIC ACID CONSTRUCT CARRYING A CARGO INTO THE CYTOPLASM OF A CELL | Scientist of Fortune S.A. (LU) | 2020-08-12 | — | — | EP | disclosed |
| WO-2019068726-A1 | CELLULAR TRANSPORT SYSTEM FOR TRANSFERRING A SULFONIC ACID CONSTRUCT CARRYING A CARGO INTO THE CYTOPLASM OF A CELL | SCIENTIST OF FORTUNE S.A. (LU) | 2019-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661398-B2 | Cellular transport system for transferring a sulfonic acid construct carrying a cargo into the cytoplasm of a cell | GOT1, GGCT, TGM2 | KMT2A 2449/4885MEN1 2818/4885ALDH1A1 1289/4885 |
| US-20210009513-A1 | CELLULAR TRANSPORT SYSTEM FOR TRANSFERRING A SULFONIC ACID CONSTRUCT CARRYING A CARGO INTO THE CYTOPLASM OF A CELL | GOT1, GGCT, TGM2 | KMT2A 2449/4885MEN1 2818/4885ALDH1A1 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.